Joseph Sobanko is a Dermatology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 228 publications with 3,165 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Civic Center Blvd
1-330s Perelman Center
Philadelphia, PA 191044306
Telephone
215-662-2737Registry record last updated 19 Nov 2011.
Clinical trials
- Kinetic Anesthesia Device Study
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LifeNet HealthProgram year20251 payment
- PolyNovo North America LLCProgram year20231 payment
- Integra LifeSciences CorporationProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
35%First-generation cephalosporins28.7%Cephalexin100%Part D≥135 patientsLincosamide Antibacterial4.1%Clindamycin Hcl100%Part D≥20 patients+ 1 more class in this area
Respiratory
30.9%RNA Synthetase Inhibitor Antibacterial30.9%Mupirocin100%Part D≥116 patientsNervous system
23.2%Opioid Agonist23.2%Tramadol Hcl90%Oxycodone-Acetaminophen10%Part D≥104 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes of invasive melanoma of the head and neck treated with Mohs micrographic surgery – A multicenter study
Journal of the American Academy of Dermatology
2023 - Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision
Journal of the American Academy of Dermatology
2021 - Systematic Review of Technical Variations for Mohs Micrographic Surgery for Melanoma
Dermatologic Surgery
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Lawrence Wechsler, MD
Hospital of the University of Pennsylvania
John Hirshfeld, MD
Hospital of the University of Pennsylvania
Noelle Frey, MD
Hospital of the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”